bibliographicCitation |
Ahrén B. Clinical results of treating type 2 diabetic patients with sitagliptin, vildagliptin or saxagliptin – diabetes control and potential adverse events. Best Practice & Research Clinical Endocrinology & Metabolism. 2009 Aug;23(4):487–98. doi: 10.1016/j.beem.2009.03.003. |